The DOI matches its Crossref record.
Carbon monoxide reverses established pulmonary hypertension
Open accessAbstract
Pulmonary arterial hypertension (PAH) is an incurable disease characterized by a progressive increase in pulmonary vascular resistance leading to right heart failure. Carbon monoxide (CO) has emerged as a potently protective, homeostatic molecule that prevents the development of vascular disorders when administered prophylactically. The data presented in this paper demonstrate that CO can also act as a therapeutic (i.e., where exposure to CO is initiated after pathology is established). In three rodent models of PAH, a 1 hour/day exposure to CO reverses established PAH and right ventricular hypertrophy, restoring right ventricular and pulmonary arterial pressures, as well as the pulmonary vascular architecture, to near normal. The ability of CO to reverse PAH requires functional endothelial nitric oxide synthase (eNOS/NOS3) and NO generation, as indicated by the inability of CO to reverse chronic hypoxia-induced PAH in eNOS-deficient (nos3−/−) mice versus wild-type mice. The restorative function of CO was associated with a simultaneous increase in apoptosis and decrease in cellular proliferation of vascular smooth muscle cells, which was regulated in part by the endothelial cells in the hypertrophied vessels. In conclusion, these data demonstrate that CO reverses established PAH dependent on NO generation supporting the use of CO clinically to treat pulmonary hypertension.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The therapeutic potential of carbon monoxide
Motterlini, R., & Otterbein, L. E. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3228 · Cited by 1,638
Self-citationDeveloping drug molecules for therapy with carbon monoxide
Romão, C. C., Blättler, W. A., Seixas, J. D., & Bernardes, G. J. L. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15317c · Cited by 524
Carbon monoxide – physiology, detection and controlled release
Heinemann, S. H., Hoshi, T., Westerhausen, M., & Schiller, A. (2014) · Chem. Commun. · doi:10.1039/c3cc49196j · Cited by 388
Inducible NOS Inhibition Reverses Tobacco-Smoke-Induced Emphysema and Pulmonary Hypertension in Mice
Seimetz, M., Parajuli, N., Pichl, A., Veit, F., Kwapiszewska, G., Weisel, F. C., Milger, K., Egemnazarov, B., Turowska, A., Fuchs, B., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.035 · Cited by 348
Ling, K., Men, F., Wang, W.-C., Zhou, Y.-Q., Zhang, H.-W., & Ye, D.-W. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01153 · Cited by 313
Heme Oxygenase-1/Carbon Monoxide: From Metabolism to Molecular Therapy
Ryter, S. W., & Choi, A. M. K. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0170tr · Cited by 308
Vergadi, E., Chang, M. S., Lee, C., Liang, O. D., Liu, X., Fernandez-Gonzalez, A., Mitsialis, S. A., & Kourembanas, S. (2011) · Circulation · doi:10.1161/circulationaha.110.978627 · Cited by 267
Pathogenic mechanisms of pulmonary arterial hypertension
Chan, S. Y., & Loscalzo, J. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.09.006 · Cited by 265
Zuckerbraun, B. S., Shiva, S., Ifedigbo, E., Mathier, M. A., Mollen, K. P., Rao, J., Bauer, P. M., Choi, J. J. W., Curtis, E., Choi, A. M. K., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.891077 · Cited by 192
Self-citation
Metadata
- Authors
- Zuckerbraun, B. S., Chin, B. Y., Wegiel, B., Billiar, T. R., Czsimadia, E., Rao, J., Shimoda, L., Ifedigbo, E., Kanno, S., & Otterbein, L. E.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2006-08-14
- Volume
- 203
- Issue
- 9
- Pages
- 2109-2119
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2170461611
- Cited by
- 158
- References
- 0
- FWCI
- 3.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.